# Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity

> **NCT02798679** · — · COMPLETED · sponsor: **University of Minnesota** · enrollment: 40 (actual)

## Conditions studied

- Cardiotoxicity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02798679
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798679, "Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02798679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*